Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan Ethosomal Gel vs Triamcinolone for Keloids
NCT05893108Phase 2Unknown
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of losartan in keloid (2 arms). Primary endpoint: The Patient and Observer Scar Assessment Scale Score (POSAS 3.0) at 12 weeks. Status: unknown.
02
Drugs
losartan
03
Conditions
keloid
Beyond the preview
Go deeper on NCT05893108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05893108.